Optimization of peptide arrays for studying antibodies to hepatitis C virus continuous epitopes

Journal of Immunological Methods

Volumn 402, Issue 1-2, 2014, Pages 35-42

  Ruwona, Tinashe B ^a   Mcbride, Ryan ^a   Chappel, Rebecca ^a   Head, Steven R ^a   Ordoukhanian, Phillip ^a   Burton, Dennis R ^a   Law, Mansun ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

E1E2 glycoprotein; HCV; Peptide array

Indexed keywords

BIOLOGICAL MARKER; BUFFER; E1 PROTEIN, HEPATITIS C VIRUS; EPITOPE; ESTER; GLYCOPROTEIN E2, HEPATITIS C VIRUS; HEPATITIS C ANTIBODY; N HYDROXYSUCCINIMIDE; N-HYDROXYSUCCINIMIDE; POLYVINYL ALCOHOL; SUCCINIMIDE DERIVATIVE; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD; CHEMISTRY; E1E2 GLYCOPROTEIN; HCV; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; IMMUNOLOGY; PEPTIDE ARRAY; PEPTIDE LIBRARY; PROTEIN MICROARRAY; RABBIT; REPRODUCIBILITY;

E1E2 GLYCOPROTEIN; HCV; PEPTIDE ARRAY;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; BUFFERS; EPITOPES; ESTERS; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HIGH-THROUGHPUT SCREENING ASSAYS; PEPTIDE LIBRARY; POLYVINYL ALCOHOL; PROTEIN ARRAY ANALYSIS; RABBITS; REPRODUCIBILITY OF RESULTS; SUCCINIMIDES; VIRAL ENVELOPE PROTEINS;

EID: 84888324178     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.11.005     Document Type: Article

References (41)

1. Adamczyk M., Gebler J.C., Reddy R.E., Yu Z. A chemoselective method for site-specific immobilization of peptides via aminooxy group. Bioconjug. Chem. 2001, 12:139.
2. Andresen H., Bier F.F. Peptide microarrays for serum antibody diagnostics. Methods Mol. Biol. 2009, 509:123.
3. Blixt O., Head S., Mondala T., Scanlan C., Huflejt M.E., Alvarez R., Bryan M.C., Fazio F., Calarese D., Stevens J., Razi N., Stevens D.J., Skehel J.J., van Die I., Burton D.R., Wilson I.A., Cummings R., Bovin N., Wong C.H., Paulson J.C. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17033.
4. Broering T.J., Garrity K.A., Boatright N.K., Sloan S.E., Sandor F., Thomas W.D., Szabo G., Finberg R.W., Ambrosino D.M., Babcock G.J. Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. J. Virol. 2009, 83:12473.
5. Choo Q.L., Kuo G., Ralston R., Weiner A., Chien D., Van Nest G., Han J., Berger K., Thudium K., Kuo C., et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:1294.
6. Cretich M., Damin F., Pirri G., Chiari M. Protein and peptide arrays: recent trends and new directions. Biomol. Eng. 2006, 23:77.
7. Deng L., Zhong L., Struble E., Duan H., Ma L., Harman C., Yan H., Virata-Theimer M.L., Zhao Z., Feinstone S., Alter H., Zhang P. Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:7418.
8. Dubuisson J., Hsu H.H., Cheung R.C., Greenberg H.B., Russell D.G., Rice C.M. Formation and intracellular-localization of hepatitis-C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J. Virol. 1994, 68:6147.
9. Galati R., Verdina A., Falasca G., Chersi A. Increased resistance of peptides to serum proteases by modification of their amino groups. Z. Naturforsch. C. 2003, 58:558.
10. Giang E., Dorner M., Prentoe J., Dreux M., Evans M.J., Bukh J., Rice C.M., Ploss A., Burton D.R., Law M. 2012, human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:6205.
11. Keck Z.Y., Xia J., Wang Y., Wang W., Krey T., Prentoe J., Carlsen T., Li A.Y., Patel A.H., Lemon S.M., Bukh J., Rey F.A., Foung S.K. Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate. PLoS Pathog. 2012, 8:e1002653.
12. Kogot J.M., Sarkes D.A., Val-Addo I., Pellegrino P.M., Stratis-Cullum D.N. Increased affinity and solubility of peptides used for direct peptide ELISA on polystyrene surfaces through fusion with a polystyrene-binding peptide tag. BioTechniques 2012, 52:95.
13. Kong L., Giang E., Nieusma T., Robbins J.B., Deller M.C., Stanfield R.L., Wilson I.A., Law M. Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33. J. Virol. 2012, 86:13085.
14. Kong L., Giang E., Robbins J.B., Stanfield R.L., Burton D.R., Wilson I.A., Law M. Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9499.
15. Kuiken C., Simmonds P. Nomenclature and numbering of the hepatitis C virus. Methods Mol. Biol. 2009, 510:33.
16. Kuiken C., Combet C., Bukh J., Shin I.T., Deleage G., Mizokami M., Richardson R., Sablon E., Yusim K., Pawlotsky J.M., Simmonds P., Los Alamos H.I.V.D.G. A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology 2006, 44:1355.
17. Lees A., Sen G., LopezAcosta A. Versatile and efficient synthesis of protein-polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry. Vaccine 2006, 24:716.
18. MacBeath G. Protein microarrays and proteomics. Nat. Genet. 2002, 32(Suppl.):526.
19. Maertens G., Dekeyser F., Van Geel A., Sablon E., Bosman F., Zrein M., Pollet D. Confirmation of HCV antibodies by the line immunoassay INNO-LIA HCV Ab III. Methods Mol. Med. 1999, 19:11.
20. Meunier J.C., Russell R.S., Goossens V., Priem S., Walter H., Depla E., Union A., Faulk K.N., Bukh J., Emerson S.U., Purcell R.H. Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus. J. Virol. 2008, 82:966.
21. Meyer K., Banerjee A., Frey S.E., Belshe R.B., Ray R. A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection. PLoS One 2011, 6:e23699.
22. Morin T.J., Broering T.J., Leav B.A., Blair B.M., Rowley K.J., Boucher E.N., Wang Y., Cheslock P.S., Knauber M., Olsen D.B., Ludmerer S.W., Szabo G., Finberg R.W., Purcell R.H., Lanford R.E., Ambrosino D.M., Molrine D.C., Babcock G.J. Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees. PLoS Pathog. 2012, 8:e1002895.
23. Niveleau A., Bruno C., Drouet E., Brebant R., Sergeant A., Troalen F. Grafting peptides onto polystyrene microplates for ELISA. J. Immunol. Methods 1995, 182:227.
24. Pejchal R., Doores K.J., Walker L.M., Khayat R., Huang P.S., Wang S.K., Stanfield R.L., Julien J.P., Ramos A., Crispin M., Depetris R., Katpally U., Marozsan A., Cupo A., Maloveste S., Liu Y., McBride R., Ito Y., Sanders R.W., Ogohara C., Paulson J.C., Feizi T., Scanlan C.N., Wong C.H., Moore J.P., Olson W.C., Ward A.B., Poignard P., Schief W.R., Burton D.R., Wilson I.A. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 2011, 334:1097.
25. Potter J.A., Owsianka A.M., Jeffery N., Matthews D.J., Keck Z.Y., Lau P., Foung S.K., Taylor G.L., Patel A.H. Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody. J. Virol. 2012, 86:12923.
26. Ray R., Meyer K., Banerjee A., Basu A., Coates S., Abrignani S., Houghton M., Frey S.E., Belshe R.B. Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins. J. Infect. Dis. 2010, 202:862.
27. Reimer U., Reineke U., Schneider-Mergener J. Peptide arrays: from macro to micro. Curr. Opin. Biotechnol. 2002, 13:315.
28. Reineke U., Ivascu C., Schlief M., Landgraf C., Gericke S., Zahn G., Herzel H., Volkmer-Engert R., Schneider-Mergener J. Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences. J. Immunol. Methods 2002, 267:37.
29. Rosa D., Campagnoli S., Moretto C., Guenzi E., Cousens L., Chin M., Dong C., Weiner A.J., Lau J.Y., Choo Q.L., Chien D., Pileri P., Houghton M., Abrignani S. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1759.
30. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467.
31. Selo I., Negroni L., Creminon C., Grassi J., Wal J.M. Preferential labeling of alpha-amino N-terminal groups in peptides by biotin, application to the detection of specific anti-peptide antibodies by enzyme immunoassays. J. Immunol. Methods 1996, 199:127.
32. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 2005, 5:558.
33. Simmonds P., Bukh J., Combet C., Deleage G., Enomoto N., Feinstone S., Halfon P., Inchauspe G., Kuiken C., Maertens G., Mizokami M., Murphy D.G., Okamoto H., Pawlotsky J.M., Penin F., Sablon E., Shin I.T., Stuyver L.J., Thiel H.J., Viazov S., Weiner A.J., Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42:962.
34. Sun L., Rush J., Ghosh I., Maunus J.R., Xu M.Q. Producing peptide arrays for epitope mapping by intein-mediated protein ligation. BioTechniques 2004, 37:430. (438, 440 passim).
35. Tarr A.W., Urbanowicz R.A., Jayaraj D., Brown R.J., McKeating J.A., Irving W.L., Ball J.K. Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization. J. Virol. 2012, 86:2739.
36. Triyatni M., Vergalla J., Davis A.R., Hadlock K.G., Foung S.K., Liang T.J. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Virology 2002, 298:124.
37. Walker L.M., Sok D., Nishimura Y., Donau O., Sadjadpour R., Gautam R., Shingai M., Pejchal R., Ramos A., Simek M.D., Geng Y., Wilson I.A., Poignard P., Martin M.A., Burton D.R. Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20125.
38. Weiner A.J., Geysen H.M., Christopherson C., Hall J.E., Mason T.J., Saracco G., Bonino F., Crawford K., Marion C.D., Crawford K.A., et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:3468.
39. Wu P., Grainger D.W. Comparison of hydroxylated print additives on antibody microarray performance. J. Proteome Res. 2006, 5:2956.
40. Zhang P., Zhong L.L., Struble E.B., Watanabe H., Kachko A., Mihalik K., Virata-Theimer M.L., Alter H.J., Feinstone S., Major M. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7537.
41. Zhu X., McBride R., Nycholat C.M., Yu W., Paulson J.C., Wilson I.A. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors. J. Virol. 2012, 86:13371.